Cerebellar motor and non-motor contributions to dystonia pathophysiology and treatment

Dystonia has long been defined by what it does to the body: sustained or intermittent abnormal movements and postures that twist muscles into involuntary contortions. But a sweeping new synthesis published in the journal Dystonia argues that this narrow diagnostic lens misses half the story. Researchers from Baylor College of Medicine and Texas Children’s Hospital, led by Linda H. Kim, Cheryl Brandenburg, and Roy V. Sillitoe, contend that dystonia’s non-motor symptoms—particularly sleep disturbances, pain, and psychiatric burdens—are critical yet underexplored concerns that affect people of all ages. Their review positions the cerebellum, a brain structure traditionally relegated to motor coordination, as a central hub linking motor and non-motor domains, and as a compelling target for more comprehensive treatments.

The cerebellum has historically been appreciated for controlling smooth movement and motor learning. However, emerging research over the past two decades has expanded its role profoundly to encompass cognition, memory, language, mood, and sleep regulation. Conditions involving cerebellar dysfunction—including dystonia, Parkinson’s disease, autism spectrum disorder, and Cerebellar Cognitive Affective Syndrome—exemplify the intricate interplay between cerebellar dysfunction and both motor and non-motor symptoms. The overlapping challenges in these conditions suggest a broader, systems-level interaction between motor deficits and non-motor symptoms, with the cerebellum as a central hub. This mini review explores this complexity in the context of dystonia, highlighting a pressing need to better understand sleep, cognitive dysfunctions, and aberrant plasticity for the purpose of creating more comprehensive therapeutic strategies.

Dystonic motor symptoms can occur in various forms, from focal dystonia affecting isolated body parts like the neck in cervical dystonia or the hand with writer’s cramp, to segmental dystonia affecting contiguous muscles, to generalized dystonia involving larger muscle groups distributed across the body. The severity of these symptoms often fluctuates, influenced by factors such as stress, fatigue, and voluntary movement. The pathophysiology of these motor symptoms is complex and multifactorial, involving a broad dystonia network dysfunction rippling across the basal ganglia, thalamus, cortex, and cerebellum. Although much of the literature has historically focused on task-specific focal dystonia, substantial evidence now demonstrates that network-level abnormalities also characterize non-task-specific focal dystonia and generalized dystonia, including widespread cortical dysfunction, impaired inhibition, and abnormal connectivity across basal ganglia-thalamo-cortical and cerebello-thalamo-cortical loops.

Interestingly, both task-specific and non-task focal dystonia involve disruptions in the basal ganglia and cerebellum, yet their underlying mechanisms also diverge. Compared to non-task dystonia, which involves more isolated dysfunction in the somatosensory cortex, task-specific focal dystonia engages cortical network dysfunction, with broader interactions among functional cortical domains whose involvement depends on the task. For example, laryngeal dystonia is associated with the parietal cortex, inferior frontal gyrus, and anterior insula, while musician’s dystonia involves the primary and secondary sensorimotor cortex and middle frontal gyrus, reflecting the task specificity of different focal dystonias. Importantly, dystonia is not restricted to primary motor circuits, and multimodal cortical regions that integrate motor, sensory, cognitive, and affective information are also implicated across dystonia subtypes, underscoring that dystonia reflects disturbances within a distributed network rather than isolated motor circuits.

Non-motor symptoms are highly prevalent in dystonia. Pain affects 55% to 89% of individuals with cervical dystonia, and approximately 30% to 40% across other focal forms. Neuropsychiatric symptoms such as depression and anxiety are markedly elevated across idiopathic dystonia compared to controls, with cervical dystonia showing the highest burden, where up to 90% of individuals may meet criteria for a psychiatric diagnosis. Psychiatric symptoms, particularly anxiety and depression, sometimes precede the onset of motor signs or appear in unaffected relatives, suggesting shared neurobiological substrates rather than secondary effects. Stress, self-consciousness, and physical factors like walking, carrying objects, or fatigue can exacerbate torticollis, blurring the boundary between motor and affective manifestations. The available evidence suggests that dystonia reflects network-level dysfunction rather than pathology confined to a single brain region, with abnormalities across the cortico-striato-thalamo-cortical and cortico-cerebello-thalamo-cortical circuits contributing to both motor and non-motor symptoms.

Sleep disturbances, including insomnia, restless sleep, and difficulty maintaining sleep, occur in roughly 40% to 70% of individuals with adult-onset dystonia, particularly in cervical dystonia. Despite evidence that poor sleep can impair motor learning, cognitive function, and overall wellbeing, they remain underappreciated. Research in individuals recovering from ischemic stroke suggests that sleep enhances implicit motor learning and motor memory consolidation, particularly when it occurs between practice and testing. Thus, to improve motor outcomes in dystonia, it is important to consider how poor sleep affects cognition and how restoring sleep can support motor recovery. Understanding the interplay between motor and non-motor symptoms and how deficits in one functional domain can perpetuate dysfunction or be leveraged for recovery in others will be crucial for developing comprehensive therapies.

While the basal ganglia have traditionally been implicated in dystonia, growing evidence points to the cerebellum as a critical player, offering new insights into dystonia’s pathophysiology as a modulator of motor output and as a potential driver of the disease. Irregular cerebellar spiking activity emerges as a consistent feature across different pharmacological, genetic, optogenetic, and circuit-based animal models of dystonia. This may involve aberrant spiking from Purkinje cells and/or the cerebellar nuclei, disrupted climbing fiber inputs, and altered cerebellar-thalamic communication. Notably, cerebellar abnormalities in these models are not secondary to basal ganglia dysfunction but rather appear to play a causative role in symptom generation. For instance, in the DYT1 mouse model, irregular cerebellar output precedes dystonic movements and can be suppressed by pharmacological silencing of the cerebellar nuclei. Indeed, cerebellar deep brain stimulation can not only restore movement in mouse models of movement disorders such as dystonia, tremor, and ataxia, but it can also restore sleep deficits in dystonic mice. This is particularly exciting since sleep disruptions across various mouse models of movement disorders have been shown to be dependent on cerebellar dysfunction but not motor symptoms, and addressing only motor symptoms fails to rescue poor sleep in both mice and humans.

Recent work has also highlighted the cerebellum’s unique role in sleep-dependent memory consolidation and sensorimotor recalibration. During sleep, cerebellar-thalamocortical coherence changes dynamically across different sleep stages, but spike timing between the motor cortex and cerebellum remains temporally correlated across both active and offline states. These findings suggest that neural patterns engaged during waking behavior may be replayed during sleep, potentially supporting offline learning and refinement of motor output. This idea is further supported by observations in neonatal rodents, where cerebellar output is required for the development of precise sensorimotor predictions during rapid eye movement (REM) sleep. Specifically, thalamic responses to spontaneous twitches, which are critical for sensorimotor development, become increasingly precise during postnatal development, and this process is disrupted by inactivation of the interposed nucleus. While key motor and social neurodevelopmental milestones are affected by olivocerebellar silencing in an early-onset generalized dystonia mouse model, it remains unknown whether dystonic cerebellar circuits during development fail to properly consolidate memories or whether sensorimotor predictions are negatively impacted.

At the neural systems level, a range of converging physiological abnormalities have been identified in dystonia, pointing to a widespread network dysfunction. These include abnormal basal ganglia firing patterns, greater low-frequency oscillatory activity, excessive low-frequency motor drive, disrupted sensorimotor processing, reduced central inhibition, and increased synaptic plasticity. Together, these findings point to a failure in the coordinated activity within and between sensorimotor networks, leading to the emergence of involuntary, repetitive movements and abnormal postures. Importantly, the specific phenotype of a given dystonia likely reflects the site and nature of the underlying network disruption. For example, focal hand dystonia is often linked to abnormal cortical plasticity abnormalities and somatotopic disorganization, while generalized dystonia may involve deeper disturbances across basal ganglia-thalamo-cortical and cerebello-thalamo-cortical loops. Furthermore, the same clinical phenotypes can precipitate from diverse lesion sites, which tend to be functionally connected to common remote networks. Across heterogeneous lesion sites, cervical dystonia consistently maps onto a cerebellar-somatosensory network that is also disrupted in idiopathic dystonia and preferentially connected to the most effective DBS targets.

Abnormal excessive synaptic plasticity may further contribute to dystonia pathology by failing to regulate plastic changes, and increasing maladaptive plasticity could worsen dystonic symptoms. Neurophysiological studies using techniques such as transcranial magnetic stimulation have shown enhanced long-term potentiation-like responses, reduced intracortical inhibition, and impaired sensorimotor integration in patients with dystonia. These abnormalities suggest a failure of homeostatic mechanisms that normally constrain plasticity to adaptive ranges. Further evidence comes from studies using paired associative stimulation, which reveal exaggerated and prolonged responses in dystonia patients compared to controls. This heightened plasticity may underlie the persistence of maladaptive motor patterns and task-specificity seen in disorders like musician’s dystonia. In contrast, abnormal plasticity may not be essential for all forms of dystonia, as patients with acquired hemidystonia show normal responses to PAS and high-frequency repetitive sensory stimulation. While aberrant plasticity might contribute to dystonia pathogenesis and progression, it could also provide an interesting opportunity for circuit recalibration. For example, pallidal DBS can normalize patterns of cortical excitability and restore more typical sensorimotor integration over time. Emerging studies also point to the cerebellum as a key modulator of cortical excitability and plasticity, with cerebellar inhibition protocols shown to dampen overactive cortical plasticity and improve motor performance in patients with dystonia, though results have been mixed across subtypes.

Despite having worse motor symptoms, pallidal DBS tends to be more effective in pediatric patients with dystonia than in adults. This raises important questions about how developmental plasticity and circuit maturation can shape symptom expression and treatment responsiveness. The disparity in outcomes may reflect a sensitive period during childhood in which heightened plasticity coincides with ongoing activity-dependent refinement of sensorimotor circuits. In addition, sleep disturbances can be less of a problem in some forms of early-onset dystonia, presenting a valuable model in which the integrity of sleep-dependent mechanisms that control motor learning and memory consolidation are potentially preserved. These insights underscore the importance of early diagnosis and intervention of early-life dystonic symptoms. Moreover, they argue for timing the therapeutic interventions to capitalize on different windows of plasticity to optimize outcomes. In genetic forms of dystonia, abnormal signaling may begin as early as embryogenesis, subtly altering the formation and function of key sensorimotor circuits. By contrast, acquired dystonia, particularly following perinatal insults, may interfere with circuits that were initially developing normally, only to be perturbed during a critical phase of refinement.

In a mouse model of dystonia created by lesioning the cerebellar output pathways, DBS yielded robust immediate therapeutic effects when applied to the centrolateral thalamus, a first-order downstream target of cerebellar projections. However, targeting the dorsal striatum, a second-order node in the same circuit, failed to produce similar benefits. Phenotype-specific differences in optimal DBS stimulation networks have been demonstrated in human patients with dystonia, where modulation of the striatopallidofugal axis appears most effective for cervical dystonia, whereas modulation of pallidothalamic bundles better predicts improvement in generalized dystonia, with both subtypes converging on a shared multisynaptic network involving the cerebellum and somatomotor cortex. These results underscore the importance of precise circuit-level targeting in optimizing DBS outcomes. Identifying pathways through which cerebellar disturbances propagate, and understanding when these circuits are amenable to modulation, will be critical for designing targeted neuromodulation strategies aimed at restoring balance in the circuit before pathological plasticity becomes entrenched. Importantly, harnessing neuroplasticity remains a promising therapeutic strategy even in adulthood, as the cerebellum plays a critical role in motor learning and adaptation to changing environments and retains a high capacity for plasticity even following injury.

Advancements in our understanding of biomarkers and electrophysiological signatures are paving the way for early diagnosis and more targeted treatments of dystonia. Nevertheless, the establishment of a definitive biomarker for dystonia still remains an active area of investigation. Theta oscillations in the globus pallidus have been shown to be strongly associated with dystonic symptoms, and the elevated theta interactions with weakened oscillations in the alpha, low beta, and gamma bands dynamically contribute to high contraction dystonic symptoms. Restoring the abnormal balance between these oscillations could alleviate dystonic symptoms by rebalancing the flow of motor information in the basal ganglia network. Interestingly, low beta/high beta power ratio positively correlated with both high and low muscle contractions during dystonic episodes, suggestive of it being a good biomarker for dystonia, but this remains to be experimentally tested. In addition, prominent alpha oscillations in the dentate nucleus in three patients with acquired dystonia have been reported, but the significance of these observations requires further investigation. Together, these oscillatory signatures raise the possibility that specific frequency-band abnormalities could serve as biomarkers for symptom severity or real-time control signals for adaptive DBS, although their predictive value for prognosis, treatment response, or target selection has not yet been determined. At present, these biomarkers are best viewed as promising candidates for guiding closed-loop neuromodulation rather than established tools for diagnosis or therapeutic stratification.

Dystonia is a multifaceted disorder that extends beyond its motor symptoms to include significant non-motor challenges. The cerebellum emerges as a critical player in both domains, influencing sensorimotor integration, sleep regulation, and cognitive processing. Moreover, linking cerebellar dysfunction to therapeutic strategies offers an opportunity to develop innovative treatments not only for dystonia but also for a broader range of neurological and psychiatric conditions. These findings position the cerebellum not only as a key driver of dystonia-related pathology but also as a promising target for therapeutic recalibration. Future neuromodulation strategies might benefit from leveraging sleep-dependent plasticity, developmentally informed intervention timing, and circuit-specific stimulation paradigms to optimize outcomes. By harnessing both spontaneous and induced forms of neuroplasticity, we may begin to think of ways to reshape abnormal motor networks and offer a fresh perspective for effective, personalized treatment across the lifespan. Moreover, sleep quality, often overlooked, holds immense potential as an early indicator of circuit dysfunction and a synergist of recovery. Future research should also focus on elucidating the precise mechanisms linking cerebellar dysfunction to the motor and non-motor aspects of dystonia over time. By addressing both motor and non-motor symptoms, we can move closer to improving the overall quality of life for individuals with dystonia.

Subject of Research: Cerebellar contributions to motor and non-motor symptoms in dystonia pathophysiology and treatment

Article Title: Cerebellar motor and non-motor contributions to dystonia pathophysiology and treatment

Article References: Kim, L. H., Brandenburg, C., & Sillitoe, R. V. (2026). Cerebellar motor and non-motor contributions to dystonia pathophysiology and treatment. Dystonia, 5, Article 15082. https://doi.org/10.3389/dyst.2026.15082

Image Credits: AI Generated

DOI: 10.3389/dyst.2026.15082

Keywords: dystonia, cerebellum, sleep disturbances, deep brain stimulation, neuroplasticity, non-motor symptoms, basal ganglia, neuromodulation, Cerebellar, motor, non-motor, contributions